662 reports of this reaction
1.1% of all VALPROIC ACID reports
#19 most reported adverse reaction
AGGRESSION is the #19 most commonly reported adverse reaction for VALPROIC ACID, manufactured by Actavis Pharma, Inc.. There are 662 FDA adverse event reports linking VALPROIC ACID to AGGRESSION. This represents approximately 1.1% of all 57,615 adverse event reports for this drug.
VALPROIC ACID has an overall safety score of 92 out of 100. Patients taking VALPROIC ACID who experience aggression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
AGGRESSION is a less commonly reported adverse event for VALPROIC ACID, but still significant enough to appear in the safety profile.
In addition to aggression, the following adverse reactions have been reported for VALPROIC ACID:
The following drugs have also been linked to aggression in FDA adverse event reports:
AGGRESSION has been reported as an adverse event in 662 FDA reports for VALPROIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
AGGRESSION accounts for approximately 1.1% of all adverse event reports for VALPROIC ACID, making it a notable side effect.
If you experience aggression while taking VALPROIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.